International Patent: USE OF BUFONIS VENENUM, BUFONIS VENENUM ACTIVE INGREDIENT, AND BUFONIS VENENUM ACTIVE INGREDIENT COMPOSITION IN RELIEVING INFLAMMATORY PAIN AND CANCER-INDUCED BONE PAIN

GENEVA, July 2 -- SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE filed a patent application (CN2024/143335) for “USE OF BUFONIS VENENUM, BUFONIS VENENUM ACTIVE INGREDIENT, AND BUFONIS VENENUM ACTIVE INGREDIENT COMPOSITION IN RELIEVING INFLAMMATORY PAIN AND CANCER-INDUCED BONE PAIN”. With publication no. WO/2026/129416, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 35/65

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....